Evidence map›Paper›PMID 24427543›Full record

ReviewInterface focus2013

Cancer cell sensing and therapy using affinity tag-conjugated gold nanorods.

Emir Yasun, Huaizhi Kang, Huseyin Erdal, Sena Cansiz, Ismail Ocsoy, Yu-Fen Huang, Weihong Tan

Abstract readReview
In one paragraph

Review in Interface focus, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Hollow micro and nanostructures for therapeutic and imaging applications.Journal of drug delivery science and technology · 2020
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emir YasunDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA.
Huaizhi KangDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA ; Department of Chemistry, College of Chemistry and Chemical Engineering , Xiamen University , Xiamen 361005 , People's Republic of China.
Huseyin ErdalDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA.
Sena CansizDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA.
Ismail OcsoyDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA.
Yu-Fen HuangDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA.
Weihong TanDepartment of Chemistry and Department of Physiology and Functional Genomics, Shands Cancer Center and Center for Research at the Interface of Bio/nano, UF Genetics Institute and McKnight Brain Institute , University of Florida , Gainesville, FL 32611-7200 , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Through the developments in controlling the shape of gold nanoparticles, synthesis of gold nanorods (AuNRs) can be considered as a milestone discovery in the area of nanomaterial-based cancer treatments. Besides having tuneable absorption maxima at near infrared (NIR) range, AuNRs have superior absorption cross section at NIR frequencies compared with other gold nanoparticles. When this unique optical property is combined with the specificity against cancer cells used by affinity tag conjugations, AuNRs become one of the most important nanoparticles used in both cancer cell sensing and in therapy. In this review, the impact of size and shape control of nanoparticles, especially AuNRs, on cancer cell treatments and a range of aptamer-conjugated AuNR applications in this regard are reviewed.

Indexed as

aptamergold nanorodsnear infraredphotoacoustic imagingphotothermal therapysurface plasmon resonance

Identifiers

PMID24427543
PMCPMC3638421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.